Dr Osler's relapsing fever

Article Abstract:

Fever was the main topic of discussion, during the nascent stages of medicinal studies, as it was the vital sign that had troubled physicians since the dawn of recorded medical history. Carl Wunderlitch was the first to scientifically study fever and William Osler, a teacher of John Hopkins Medical School during the 1890's taught his students the importance of control of fever and to pay close attention to all aspects of fever, from its cause to effects.

Management dynamics, Practice, Medical education, Relapsing fever, Osler, William, Sir

---

Nonpharmaceutical interventions implemented by U.S. cities during the 1918-1919 influenza pandemic

Article Abstract:

Effective handling and proper precautionary measures coupled with nonpharmaceutical interventions that could be implemented to control a situation termed pandemic are presented.

Government domestic functions, Influenza, Control, Health policy

---

Extensively drug-resistant tuberculosis

Article Abstract:

The advent of drug-resistant tuberculosis (XDR-TB) is studied. Results show the system of quarantine as a method to help control the illness and its legality and global impact.

Care and treatment, Evaluation, Prevention, Tuberculosis, Quarantine

Similar abstracts:

• Abstracts: Combined pharmacotherapies and behavioral interventions for alcohol dependence. Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence
• Abstracts: Development of a large-scale obstetric quality-improvement program that focused on the nulliparous patient at term
• Abstracts: Toward universal criteria for gestational diabetes: the 75-gram glucose tolerance test in pregnancy. What proportion of birth weight is attributable to maternal glucose among infants of diabetic women?
• Abstracts: Angiogenesis as a therapeutic target. Clinical applications of angiogenic growth factors and their inhibitors
• Abstracts: Depression and cardiovascular disease: Healing the broken-hearted. Influence of patients' requests for direct-to-consumer advertised antidepressants

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.